Recent research has provided new insights on the epidemiology, pathology and
immunology of canine leishmaniosis (CanL) and its genetic basis. The prevalence of …

In dogs with symptomatic or asymptomatic leishmaniosis, Leishmania infantum appears to
induce a mixed Th1/Th2 immune response that in the sick dog may eventually result in …

Human visceral leishmaniasis (VL) and canine visceral leishmaniasis (CVL) are the most
important emerging diseases with high prevalence in Latin American countries and are …

Human vaccination against leishmaniasis using live Leishmania was used in Middle East
and Russia (1941–1980). First-generation vaccines, composed by killed parasites induce …

Immune control of Leishmania infantum, the causative agent of most canine leishmaniosis
(CanL), requires a balancing act between inflammatory and regulatory responses. This …

Canine leishmaniosis (CanL) is a vector-borne disease caused by the protozoan
Leishmania (Leishmania) infantum species [syn. L.(L.) infantum chagasi species in the …

Canine leishmaniosis (CanL) is caused by the parasite Leishmania infantum and is a
systemic disease, which can present with variable clinical signs, and clinicopathological …

Canine leishmaniosis caused by Leishmania infantum (Syn. L. chagasi) is an important
zoonosis with a complex pathogenesis. Parasite transmission occurs via female sandflies …

The control of infection by Leishmania infantum (syn. Leishmania chagasi) in dogs is
essential to stop the current spread of zoonotic visceral leishmaniasis. The past few years …

Leishmaniasis is the third most important vector-borne disease worldwide. Visceral
leishmaniasis (VL) is a severe and frequently lethal protozoan disease of increasing …